Business.Scoop » DIA And CoRE Gathering Key Healthcare Experts In Neutral Forum To Discuss Regulatory News And Drug Development
Business Scoop provides news and views on Business and Markets from New Zealand
Source: scoop.co.nz
Stay updated with breaking news from Global Head Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Business Scoop provides news and views on Business and Markets from New Zealand
/PRNewswire/ -- Novartis today announced robust data from the primary analysis of the pivotal Phase II ELARA trial of Kymriah® (tisagenlecleucel) in patients...
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis Kymriah® pivotal trial demonstrates strong response rates and a remarkable safety profile in relapsed or refractory follicular lymphoma